COVID-19 related immune hemolysis and thrombocytopenia
- PMID: 32776538
- PMCID: PMC7436763
- DOI: 10.1002/jmv.26402
COVID-19 related immune hemolysis and thrombocytopenia
Abstract
The current pandemic due to coronavirus disease 2019 (COVID-19) has posed an unprecedented challenge for the medical communities, various countries worldwide, and their citizens. Severe acute respiratory syndrome coronavirus 2 has been studied for its various pathophysiological pathways and mechanisms through which it causes COVID-19. In this study, we discussed the immunological impact of COVID-19 on the hematological system, platelets, and red blood cells.
Keywords: coronavirus; hemolysis; immunity.
© 2020 Wiley Periodicals LLC.
Conflict of interest statement
The authors declare that there are no conflict of interests.
Figures
References
-
- Ahmed MZ, Khakwani M, Venkatadasari I, et al. Thrombocytopenia as an initial manifestation of COVID‐19; case series and literature review. Br J Haematol. 2020;189:1057‐1058. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical